---
title: "WuXi AppTec Announces Key Governance Changes Post-EGM"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258516031.md"
description: "WuXi AppTec Co., Ltd. (HK:2359) announced key governance changes following an extraordinary general meeting, where resolutions included the cancellation of the supervisory committee and amendments to the articles of association. The meeting had strong shareholder participation, with 51.9894% of voting shares represented. Analysts currently rate the stock as a Buy, with a price target of HK$132.00. WuXi AppTec operates in the pharmaceutical and biotechnology industry, providing laboratory and manufacturing services."
datetime: "2025-09-23T11:39:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258516031.md)
  - [en](https://longbridge.com/en/news/258516031.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258516031.md)
---

# WuXi AppTec Announces Key Governance Changes Post-EGM

WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an update.

WuXi AppTec Co., Ltd. recently held an extraordinary general meeting where key resolutions were passed, including the cancellation of the supervisory committee and amendments to the articles of association. The meeting saw participation from a significant number of shareholders, with 51.9894% of the total shares with voting rights represented, indicating strong shareholder engagement in the company’s governance matters.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$132.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

**More about WuXi AppTec Co., Ltd. Class H**

WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical and biotechnology industry. The company is known for providing comprehensive laboratory and manufacturing services that enable pharmaceutical, biotech, and medical device companies to advance discoveries and deliver new treatments to patients.

**Average Trading Volume:** 9,160,998

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$341.4B

For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)

## Related News & Research

- [BE Semiconductor Industries NV (OTCMKTS:BESIY) Short Interest Update](https://longbridge.com/en/news/284104834.md)
- [Ross Gerber Says Tesla Faces Potential SpaceX Merger As Investors Question Strategic Direction, 'It Will All Be Wrapped Up As One Ball of Elon'](https://longbridge.com/en/news/284090910.md)
- [Assessing Knowledge Atlas Technology (SEHK:2513) Valuation After Sharp Moves And Mixed Fundamentals](https://longbridge.com/en/news/284115474.md)
- [Intel (INTC) Valuation Check After AI Driven Earnings Beat And Upbeat Outlook](https://longbridge.com/en/news/284107502.md)
- [02:00 ETThe Building & Furniture Category Highlights Sustainable and Human‑Centric Design at the 139th Canton Fair](https://longbridge.com/en/news/284100607.md)